Annual Long Term Debt
$3.19 M
-$369.00 K-10.37%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual long term debt is currently $3.19 million, with the most recent change of -$369.00 thousand (-10.37%) on 31 December 2023. During the last 3 years, it has risen by +$3.19 million (+100.00%). CPRX annual long term debt is now -18.13% below its all-time high of $3.89 million, reached on 31 December 2021.CPRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2.89 M
-$102.00 K-3.41%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly long term debt is currently $2.89 million, with the most recent change of -$102.00 thousand (-3.41%) on 30 September 2024. Over the past year, it has dropped by -$393.00 thousand (-11.97%). CPRX quarterly long term debt is now -30.03% below its all-time high of $4.13 million, reached on 31 March 2021.CPRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.4% | -12.0% |
| 3 y3 years | +100.0% | -27.3% |
| 5 y5 years | +100.0% | +298.1% |
CPRX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.1% | -27.3% | at low | |
| 5 y | 5 years | -18.1% | -30.0% | ||
| alltime | all time | -18.1% | -30.0% |
Catalyst Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.89 M(-3.4%) |
| June 2024 | - | $2.99 M(-3.2%) |
| Mar 2024 | - | $3.09 M(-3.0%) |
| Dec 2023 | $3.19 M(-10.4%) | $3.19 M(-2.9%) |
| Sept 2023 | - | $3.28 M(-2.8%) |
| June 2023 | - | $3.38 M(-2.7%) |
| Mar 2023 | - | $3.47 M(-2.5%) |
| Dec 2022 | $3.56 M(-8.7%) | $3.56 M(-2.4%) |
| Sept 2022 | - | $3.64 M(-2.3%) |
| June 2022 | - | $3.73 M(-2.2%) |
| Mar 2022 | - | $3.81 M(-2.1%) |
| Dec 2021 | $3.89 M | $3.89 M(-2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $3.97 M(-1.9%) |
| June 2021 | - | $4.05 M(-1.9%) |
| Mar 2021 | - | $4.13 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| June 2020 | - | $0.00(-100.0%) |
| Mar 2020 | - | $568.40 K(-12.2%) |
| Dec 2019 | $647.50 K(>+9900.0%) | $647.50 K(-10.8%) |
| Sept 2019 | - | $725.70 K(-9.4%) |
| June 2019 | - | $801.30 K(-8.4%) |
| Mar 2019 | - | $875.10 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Catalyst Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual long term debt year-on-year change?
- What is Catalyst Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly long term debt year-on-year change?
What is Catalyst Pharmaceuticals annual long term debt?
The current annual long term debt of CPRX is $3.19 M
What is the all time high annual long term debt for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual long term debt is $3.89 M
What is Catalyst Pharmaceuticals annual long term debt year-on-year change?
Over the past year, CPRX annual long term debt has changed by -$369.00 K (-10.37%)
What is Catalyst Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of CPRX is $2.89 M
What is the all time high quarterly long term debt for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly long term debt is $4.13 M
What is Catalyst Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, CPRX quarterly long term debt has changed by -$393.00 K (-11.97%)